Hajime Uno (H Uno)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 35

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Biometrics

JCO precision oncology

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Sep 02 2008

United States

Assistant Professor :: Medical Oncology

Publications

Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Regression models for average hazard. Biometrics 80 (2) (2024)
Ying Cui, Bo Huang, L U Mao, Hajime Uno, Lee-Jen Wei, Lu Tian
Inferences for the distribution of the duration of response in a comparative clinical study. Clinical trials (London, England) (2024)
Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Regression models for average hazard. Biometrics 80 (2) (2024)
Hajime Uno, Miki Horiguchi
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO precision oncology 8 (2024)
Hajime Uno, Miki Horiguchi
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO precision oncology 8 (2024)
Hajime Uno, Miki Horiguchi
Biomarkers in Oncology: Complexities in Biomarker-Driven Studies and Statistical Analysis. JCO precision oncology 8 (2024)
Hajime Uno, Lu Tian, Miki Horiguchi, Satoshi Hattori, Kenneth L Kehl
Regression models for average hazard. Biometrics 80 (2) (2024)
Kenneth L Kehl, Hajime Uno, Alexander Gusev, Stefan Groha, Samantha Brown, Jessica A Lavery, Deborah Schrag, Katherine S Panageas
Elucidating Analytic Bias Due to Informative Cohort Entry in Cancer Clinico-genomic Datasets. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Miki Horiguchi, Lu Tian, Hajime Uno
On assessing survival benefit of immunotherapy using long-term restricted mean survival time. Statistics in medicine (2023)
Kenneth L Kehl, Hajime Uno, Alexander Gusev, Stefan Groha, Samantha Brown, Jessica A Lavery, Deborah Schrag, Katherine S Panageas
Elucidating Analytic Bias Due to Informative Cohort Entry in Cancer Clinico-genomic Datasets. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Jennifer W Mack, Colin Cernik, Hajime Uno, Cecile A Laurent, Lauren Fisher, Lanfang Xu, Julie Munneke, Nancy Cannizzaro, Mallory Casperson, Corey M Schwartz, Joshua R Lakin, Robert M Cooper, Andrea Altschuler, Lori S Wiener, Chun R Chao, Lawrence H Kushi
Quality of End-of-Life Care Among Adolescents and Young Adults With Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kenneth L Kehl, Hajime Uno, Alexander Gusev, Stefan Groha, Samantha Brown, Jessica A Lavery, Deborah Schrag, Katherine S Panageas
Elucidating analytic bias due to informative cohort entry in cancer clinico-genomic datasets. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Kenneth L Kehl, Hajime Uno, Alexander Gusev, Stefan Groha, Samantha Brown, Jessica A Lavery, Deborah Schrag, Katherine S Panageas
Elucidating Analytic Bias Due to Informative Cohort Entry in Cancer Clinico-genomic Datasets. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Miki Horiguchi, Lu Tian, Hajime Uno
On assessing survival benefit of immunotherapy using long-term restricted mean survival time. Statistics in medicine 42 (8) (2023)
Zoe Guan, Theodore Huang, Anne Marie McCarthy, Kevin Hughes, Alan Semine, Hajime Uno, Lorenzo Trippa, Giovanni Parmigiani, Danielle Braun
Combining Breast Cancer Risk Prediction Models. Cancers 15 (4) (2023)
Zoe Guan, Theodore Huang, Anne Marie McCarthy, Kevin Hughes, Alan Semine, Hajime Uno, Lorenzo Trippa, Giovanni Parmigiani, Danielle Braun
Combining Breast Cancer Risk Prediction Models. Cancers 15 (4) (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine 42 (7) (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine 42 (7) (2023)
Jennifer W Mack, Colin Cernik, Hajime Uno, Lanfang Xu, Cecile A Laurent, Lauren Fisher, Nancy Cannizzaro, Julie Munneke, Robert M Cooper, Joshua R Lakin, Corey M Schwartz, Mallory Casperson, Andrea Altschuler, Lori S Wiener, Lawrence H Kushi, Chun R Chao
Discussions About Goals of Care and Advance Care Planning Among Adolescents and Young Adults With Cancer Approaching the End of Life. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Miki Horiguchi, Lu Tian, Hajime Uno
On assessing survival benefit of immunotherapy using long-term restricted mean survival time. Statistics in medicine 42 (8) (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine 42 (7) (2023)
Rebekah L Wilson, Dong-Woo Kang, Meghan Tahbaz, Mary Norris, Hajime Uno, Jennifer A Ligibel, Jeffrey P Guenette, Cameron Christopher, Christina M Dieli-Cornwright
Improving Cognitive Function Through High-Intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy: Protocol for a Randomized Controlled Trial. JMIR research protocols 12 (2023)
Hajime Uno, Miki Horiguchi
Ratio and difference of average hazard with survival weight: New measures to quantify survival benefit of new therapy. Statistics in medicine (2023)
Zoe Guan, Theodore Huang, Anne Marie McCarthy, Kevin Hughes, Alan Semine, Hajime Uno, Lorenzo Trippa, Giovanni Parmigiani, Danielle Braun
Combining Breast Cancer Risk Prediction Models. Cancers 15 (4) (2023)
Kenneth L Kehl, Hajime Uno, Alexander Gusev, Stefan Groha, Samantha Brown, Jessica A Lavery, Deborah Schrag, Katherine S Panageas
Elucidating Analytic Bias Due to Informative Cohort Entry in Cancer Clinico-genomic Datasets. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Matthew B Yurgelun, Hajime Uno, C Sloane Furniss, Chinedu Ukaegbu, Miki Horiguchi, Amal Yussuf, Holly LaDuca, Anu Chittenden, Judy E Garber, Sapna Syngal
Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk Assessment. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (35) (2022)
Debra P Ritzwoller, Michael J Hassett, Hajime Uno
Regarding the Utility of Unstructured Data and Natural Language Processing for Identification of Breast Cancer Recurrence. JCO clinical cancer informatics 5 (2021)
C Sloane Furniss, Matthew B Yurgelun, Chinedu Ukaegbu, Pamela E Constantinou, Catherine C Lafferty, Eliana R Talcove-Berko, Alison N Schwartz, Jill E Stopfer, Meghan Underhill-Blazey, Barbara Kenner, Scott H Nelson, Sydney Okumura, Sherman Law, Alicia Y Zhou, Tara B Coffin, Nicolette J Rodriguez, Hajime Uno, Allyson J Ocean, Florencia McAllister, Andrew M Lowy, Scott M Lippman, Alison P Klein, Lisa Madlensky, Gloria M Petersen, Judy E Garber, Michael G Goggins, Anirban Maitra, Sapna Syngal
Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer prevention research (Philadelphia, Pa.) 14 (11) (2021)
Miki Horiguchi, Hajime Uno
On permutation tests for comparing restricted mean survival time with small sample from randomized trials. Statistics in medicine 39 (20) (2020)
Lu Tian, Hua Jin, Hajime Uno, Ying Lu, Bo Huang, Keaven M Anderson, Lee-Jen Wei
On the empirical choice of the time window for restricted mean survival time. Biometrics 76 (4) (2020)
Miki Horiguchi, Michael J Hassett, Hajime Uno
Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology. Clinical trials (London, England) 17 (6) (2020)
Hajime Uno, Miki Horiguchi, Michael J Hassett
Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. The oncologist 25 (2) (2019)
Miki Horiguchi, Angel M Cronin, Masahiro Takeuchi, Hajime Uno
A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials. Statistics in medicine 37 (15) (2018)
Lu Tian, F Jiang, T Hasegawa, Hajime Uno, M Pfeffer, L J Wei
Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study. Statistics in medicine 38 (6) (2018)
Miki Horiguchi, Michael J Hassett, Hajime Uno
How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated? The oncologist 24 (7) (2018)

Hajime Uno.css-eqlu8i{font-size:small;padding-left:4px;} (H Uno)

Publication Activity (10 Years)

Top Topics

Top Venues

Hajime Uno (H Uno)